Kitano S, Kitajima M, Konishi F, Kondo H, Satomi S, Shimizu N
Department of Surgery I, Oita University Faculty of Medicine, 1-1 Idaigaoka, Yufu, Oita, 879-5593, Japan.
Surg Endosc. 2006 Sep;20(9):1348-52. doi: 10.1007/s00464-004-8247-9. Epub 2006 Jul 24.
Laparoscopic colectomy for malignant disease technically is feasible but not widely accepted because there are no large-series studies or data on long-term outcomes. A retrospective, multicenter study investigating a large series of patients was conducted in Japan to evaluate preliminary long-term results of laparoscopic surgery for colorectal cancer.
The study group comprised 2,036 patients who underwent laparoscopic colorectal resection April 1993 to August 2002 in 12 participating surgical units (Japanese Laparoscopic Surgery Study Group).
Of the 1,495 patients with colon cancer, 781 (59%) had International Union Against Cancer (UICC) stage I, 248 (19%) had stage II, and 284 (22%) had stage III disease. Cancer recurred for 61 (4.1%) of 1,367 curatively treated patients (median follow-up period, 32 months; range, 6-125 months). The 5-year survival rate was 96.7% for stage I, 94.8% for stage II, and 79.6% for stage III disease. Of the 541 patients with rectal cancer, 220 (56%) had stage I, 62 had (16%) stage II, and 108 (28%) had stage III disease. Cancer recurred for 30 (5.6%) of 476 curatively treated patients (median follow-up period, 25 months; range 6-102 months). The 5-year survival rate was 95.2% for stage I, 85.2% for stage II, and 80.8% for stage III disease.
The findings indicate that laparoscopic surgery for colorectal cancer yields an oncological outcome as good as that reported for conventional open surgery in the Japanese Registry for all disease stages.
腹腔镜结肠切除术治疗恶性疾病在技术上是可行的,但尚未被广泛接受,因为缺乏关于长期预后的大型系列研究或数据。日本开展了一项回顾性多中心研究,调查了大量患者,以评估腹腔镜手术治疗结直肠癌的初步长期结果。
研究组包括1993年4月至2002年8月在12个参与手术的单位(日本腹腔镜手术研究组)接受腹腔镜结直肠切除术的2036例患者。
在1495例结肠癌患者中,781例(59%)为国际抗癌联盟(UICC)I期,248例(19%)为II期,284例(22%)为III期疾病。1367例接受根治性治疗的患者中有61例(4.1%)癌症复发(中位随访期32个月;范围6 - 125个月)。I期疾病的5年生存率为96.7%,II期为94.8%,III期为79.6%。在541例直肠癌患者中,220例(56%)为I期,62例(16%)为II期,108例(28%)为III期疾病。476例接受根治性治疗的患者中有30例(5.6%)癌症复发(中位随访期25个月;范围6 - 102个月)。I期疾病的5年生存率为95.2%,II期为85.2%,III期为80.8%。
研究结果表明,在日本登记处,腹腔镜手术治疗结直肠癌在所有疾病阶段的肿瘤学结果与传统开放手术报告的结果一样好。